Evidence map›Paper›PMID 36478161›Full record

ArticleRevista peruana de medicina experimental y salud publica

Burden of disease of COVID-19 in the department of Nariño, Colombia, 2020-2021.

Arsenio Hidalgo-Troya, Jorge Martín Rodríguez, Anderson Rocha-Buelvas, Diana Urrego-Ricaurte

Abstract read
In one paragraph

Article in Revista peruana de medicina experimental y salud publica. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Arsenio Hidalgo-TroyaUniversidad de Nariño, Pasto-Nariño, Colombia.ORCID http://orcid.org/0000-0002-6393-8085
Jorge Martín RodríguezPontificia Universidad Javeriana, Bogotá D.C., Colombia.ORCID http://orcid.org/0000-0002-7301-7706
Anderson Rocha-BuelvasUniversidad de Nariño, Pasto-Nariño, Colombia.ORCID http://orcid.org/0000-0003-1681-3500
Diana Urrego-RicaurtePontificia Universidad Javeriana, Bogotá D.C., Colombia.ORCID http://orcid.org/0000-0002-5754-3474

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

OBJECTIVES.: To estimate the burden of disease of COVID-19 in the department of Nariño, Colombia, based on the disability-adjusted life years (DALYs) between March 2020 and August 2021. MATERIALS AND METHODS.: The description and characterization of COVID-19 cases reported between March 2020 and August 2021 was made according to age groups, sex, ethnicity, municipalities of residence and subregions of Nariño by using information from the national surveillance system SIVIGILA. Crude and cumulative mortality rates for COVID-19 were estimated for the previously described variables. Years lost due to premature death (YLL) and years lived with disability (YLD) were calculated. Total DALYs were estimated by adding YLL + YLD. These were calculated by sex, ethnicity, age group and subregions of Nariño. Relative risks were estimated from rate ratios (RR) and 95% confidence intervals for the study variables. RESULTS.: The highest morbidity, mortality and DALY rates occurred between February and September 2021, in men, in those older than 70 years, in the Afro-descendant ethnic minority group and in the Central, Obando and Juanambú subregions. The burden of disease of COVID-19 in Nariño during the study period is attributed to the YLL, which explain more than 97% of it. CONCLUSIONS.: This is one of the first studies on burden of disease at the regional level, carried out in Colombia, that employs a standardized methodology for COVID-19. This measurement would generate estimates that would allow targeting resources in an intersectoral manner, mitigating the damage to specific populations and geographic areas, especially the most vulnerable ones.

Indexed as

COVID-19EthnicityColombiaCost of IllnessHumansMinority Groups

Identifiers

PMID36478161
PMCPMC11397680

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.